ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 61. Num. 11.
Pages 1150-1158 (November 2008)

Prevalence of Obesity, Diabetes, Hypertension, Hypercholesterolemia and Metabolic Syndrome in Over 50-Year-Olds in Sanlúcar de Barrameda, Spain

Prevalencia de obesidad, diabetes, hipertensión, hipercolesterolemia y síndrome metabólico en adultos mayores de 50 años de Sanlúcar de Barrameda

Alejandro López SuárezaJavier Elvira GonzálezaManuel Beltrán RoblesaMichael AlwakilbJuan Manuel SaucedobAntonio Bascuñana QuirellaMiguel A Barón RamosaFernando Fernández Palacínc

Options

Introduction and objectives. The Spanish province of Cadiz has some of the poorest socioeconomic conditions and the highest cardiovascular morbidity and mortality rates in the country. The aim of this study was to investigate the prevalence of cardiovascular risk factors in the adult population of the city of Sanlucar de Barrameda in Cadiz. Methods. This cross-sectional population-based study involved 858 randomly selected individuals aged 50-75 years. Age- and sex-adjusted prevalences of the main cardiovascular risk factors were obtained. Results. The mean age of the study population was 61.5 years and 53.6% were women. Overall, 46% of men and 61.7% of women were illiterate; 23.7% and 7.9%, respectively, were current smokers; 30.9% and 44.8% had a sedentary lifestyle; 54% and 55.9% were obese; 29.4% and 26.1% had diabetes; 45% and 52.4% had hypertension; 40.9% and 45.1% had hypercholesterolemia; and 58.8% and 57% had metabolic syndrome as defined by NCEP/ATP-III criteria. The prevalence of all cardiovascular risk factors, except smoking, increased with age. Significant inverse associations were observed between educational level and obesity in men and between educational level and diabetes and metabolic syndrome in women. Conclusions. The prevalence of cardiovascular risk factors in individuals aged 50-75 years in Sanlucar de Barrameda was extremely high. The prevalences of obesity, diabetes, and metabolic syndrome were among the highest ever reported in Spain. A very low educational level may underlie these adverse findings.

Keywords

Obesity
Diabetes
Hypertension
Hypercholesterolemia
Metabolic syndrome

INTRODUCTION

Cardiovascular disease continues to be the leading cause of morbidity and mortality among adults in Spain. It is estimated that new coronary and cerebrovascular events occur at a rate of 250-450 per 100000 individuals per year.1 The distribution of mortality due to cardiovascular disease is not uniform throughout Spain and an accentuated north-south gradient has been confirmed. Three provinces of the Andalusian community (Cadiz, Huelva, and Seville) carry one third of the excess all-cause mortality in the whole of Spain,2 despite comprising only 8% of the Spanish population. The highest mortality rates due to ischemic heart disease are also concentrated in the south, in the Canary Islands and in Cadiz, Malaga, and Seville.3 Geographic differences related to socioeconomic and educational levels, the prevalence of cardiovascular risk factors and, to a lesser extent nowadays, the quality and accessibility of health care are factors that may explain this asymmetry.

Detailed and current knowledge of these variables is essential in order to plan prevention and intervention policies for at-risk groups. Over recent years, numerous cross-sectional studies and meta-analyses have been performed that have provided general information on the prevalence of cardiovascular risk factors in different geographical areas.4 Unfortunately, generation of this information is neither stable nor updated and lacks data from specific areas where the cardiovascular morbidity and mortality impact is very high.

We present the results of a population-based study whose aim was to investigate the prevalence of the main cardiovascular risk factors in the adult population of the city of Sanlucar de Barrameda, Cadiz, Spain.

METHODS

The Sanlucar Study

The Sanlucar Study is a population-based prospective study designed with a 2-fold objective: to establish the prevalence of the main cardiovascular risk factors in the adult population of the city of Sanlucar de Barrameda, results of which are presented in this manuscript, and to contribute information on the role of the metabolic syndrome as an independent cardiovascular risk factor in the development of atherosclerotic events, comparing 2 cohorts of individuals with and without the metabolic syndrome after a follow-up of 5 years, this work still in progress. The Sanlucar Study was carried out by the Internal Medicine Service of the Hospital Virgen del Camino of Sanlucar de Barrameda (Cadiz), and commenced in July 2006. The current analysis was performed after finalizing the inclusion period in February 2007. Thus, it is a cross-sectional, descriptive, population-based study to establish the prevalence of cardiovascular risk factors in the adult population of the city of Sanlucar de Barrameda.

Study Population and Calculation of Sample Size

Sanlucar de Barrameda is a coastal city of the province of Cadiz with a census population in 2005 of 63 509 residents, almost all Caucasian. The target population was made up of individuals between the ages of 50 and 75 years and registered in the municipality. This list, provided by the city hall in December 2005, included a total of 14 018 residents. After taking a random sample of this population, one person was appointed to contact the selected individuals by telephone to invite them to participate in the study. Those who accepted were included after an interview by the physician investigator in the outpatient unit of the hospital and after obtaining informed consent. All individuals were given a clinical report with the results of the physical examination and the laboratory tests.

The sample size of the Sanlucar Study was calculated using the age-adjusted annual incidence rate of coronary and cerebrovascular disease described in Spain,1 and an estimation of the relative risk of cardiovascular events attributable to the metabolic syndrome.5,6 An incidence rate of cardiovascular events in the population aged over 50 years of 2.8% was selected, and the relative risk attributable to the metabolic syndrome was 2.75%.

Determining a confidence interval of 95% and a statistical power of 80%, a sample size of 760 cases was calculated, which was increased by 10% to cover losses.

Inclusion and Exclusion Criteria

The individuals selected had to meet the following inclusion criteria: resident in Sanlucar de Barrameda and be listed on the municipal census, be between 50 and 75 years of age, and provide informed consent. Persons diagnosed with severe, life-threatening diseases were excluded. Other exclusion criteria were: documented diagnosis of malignant neoplasia; creatinine clearance <30 mL/min/1.73 m2 (MDRD-4 formula)7; Child stage B or C cirrhosis, cardiac or respiratory failure of any grade, as well as connective tissue disease, neurodegenerative disease or infection with HIV.

Clinical and Laboratory Data Collection Protocol

The following variables were recorded: age, sex, education level (4 categories: no schooling, primary education, vocational training or secondary education, and university studies); smoking (current smoker— smokers at inclusion and ex-smokers for less than 1 year, and non-smoker—those who had never smoked and ex-smokers for more than 1 year); alcohol consumption (non-drinkers, drinkers of 1 or 2 units per day, and drinkers of more than 2 units per day); sedentary lifestyle (walk less than 30 min daily on 5 days per week); documented diagnosis of type 2 diabetes mellitus (1997 ADA definition),8 high blood pressure (Seventh Report of the Joint National Committee),9 and hypercholesterolemia (low-density lipoprotein cholesterol [LDL-C] value >190 mg/dL or receiving treatment with statins) or receiving treatment for these conditions, and a first degree family history of early cardiovascular disease (men under 55 years and women under 65 years).

After an overnight fast, venous blood samples were taken to determine plasma levels of: glucose (enzymatic oxidation), creatinine (spectrophotometry), total cholesterol (enzymatic hydrolysis, colorimetry), high-density lipoprotein cholesterol (HDL-C) (beta lipoprotein specific antibodies, spectrophotometry), triglycerides (enzymatic hydrolysis, colorimetry), and uric acid (enzymatic oxidation), using an ILAB-600 analyzer. The LDL-C was calculated using the Friedewald formula.10

Blood pressure was measured with an OMRON 705CP automatic blood pressure monitor, using an arm cuff with a 12´40 cm bladder in obese patients with an arm circumference >35 cm. Blood pressure was measured in the outpatient office during the course of a clinical interview after the participant had been seated for 5 min. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) recorded were the mean of 3 consecutive readings with a difference in the SBP <10 mm Hg. The individuals with undiagnosed hypertension, but with a mean clinical blood pressure >140/90 mm Hg were offered confirmation via self-monitored blood pressure (SMBP) if the clinical SBP was 140-149 mm Hg or ambulatory blood pressure monitoring (ABPM) if the clinical SBP was >150 mm Hg. For the SMBP the individuals were instructed to perform 3 readings daily (before the 3 main meals and after resting, seated at the table, for at least 5 min) on 5 consecutive days, to obtain a total of 15 readings. Representative SBP and DBP values were the mean of 13 readings, after excluding the first and last readings. The 24 hour ABPM was carried out with a BR-102 blood pressure recorder (Schiller AG, Baar, Switzerland), taking daytime readings every 20 min until 22:00 and night-time readings every 30 min until 7:00. Representative values for SBP and DBP were the means of the 24 h readings. The body mass index (BMI) was calculated by dividing the weight (in kilos) by the square of the height (in meters). The waist circumference was measured using a semi-rigid measuring tape, with the individual in decubitus, at the point midway between the last rib and the upper border of the iliac crest. Obesity was considered to be a BMI ≥30 and overweight, a BMI ≥27. In individuals with undiagnosed diabetes, a new diagnosis of diabetes was considered to be a plasma glucose >126 mg/dL and elevated fasting plasma glucose, a blood glucose >100 and <126 mg/dL; a new diagnosis of hypertension was considered to be a reading of ≥135/85 mm Hg by SMBP or ABPM in individuals with previously undiagnosed hypertension, and a new diagnosis of hypercholesterolemia was an LDL-C level ≥190 mg/dL in individuals with previously undiagnosed hypercholesterolemia. For the diagnosis of the metabolic syndrome the modified NCEP/ATP-III definition was used.11

Statistical Analysis

The normality of the quantitative variables was confirmed using the Kolmogorov-Smirnov test. For the description of the continuous variables the mean (standard deviation), or the median in the case of non-normal distribution, was used. The quantitative variables with a non-normal distribution were transformed into their respective natural logarithms. The qualitative variables are expressed as a proportion and 95% confidence interval. For the bivariate analysis of parametric variables the difference of means test (Student t test) was used and for comparison of proportions the c2 test. Logistic regression analysis with the variable to be analyzed was performed to assess, from the odds ratio (OR), the relationship between educational level and each of the cardiovascular risk factors, differentiating by sex. In all cases the variables smoking, alcohol, a sedentary lifestyle, and age were included as control variables, in order to consider their potential confounding effect. For this analysis, the educational level was transformed into a dichotomous variable "no schooling" and "some schooling" (including primary education, secondary education, vocational training, and university studies). A P value less than .05 was considered significant. The analysis were performed with SPSS, version 11.0.

RESULTS

From July 2006 until February 2007, 1174 individuals were invited to participate in the study; 273 (23.2%) refused to participate, 37 (3.1%) were excluded (19 for malignant neoplasms, 7 for neurodegenerative disease, 4 for chronic heart failure, 4 for chronic respiratory insufficiency, 4 for advanced chronic renal failure, 3 for cirrhosis, and 3 for connective tissue disorders) and 6 were not located. The total number of valid cases finally included was 858 (73.1%). The mean age and sex proportion of the sample (46.4% men with a mean age of 61.9 years and 53.6% women with a mean age of 61.1 years) did not differ significantly from the target population (48.6% men with a mean age of 61.1 years and 51.4% women with a mean age of 61.6 years).

Tables 1, 2, and 3 show the demographic, clinical, and analytical data of the study sample, and the prevalence of cardiovascular risk factors according to age and sex. Table 4 compares the prevalences of the cardiovascular risk factors between the group of persons with no schooling and the group that had some schooling.

Alcohol, Smoking, Physical Activity, and Educational Level

Significantly more men were active smokers and drank more than 2 units per day (Table 1), with a tendency to decrease in the oldest age groups (Table 3). The prevalence of a sedentary lifestyle was high, more than one third of cases, predominantly among the women and increasing progressively with age (Tables 1 and 3).

The most notable result in the sample group was a very low level of education, as 61.7% of the women and 46% of the men admitted to not having completed primary studies and not being able to read or write. Just 10.6% of the men and 3.1% of the women had had the opportunity to study at the secondary or university level. By deciles of age, a significant decrease in illiteracy was seen in the youngest group. This reduction was seen in both sexes, though less marked among the women (Tables 1 and 3). In the bivariate analysis, the group of individuals with no schooling had a significantly higher percentage of obesity, diabetes, hypertension and the metabolic syndrome. The only predominant risk factor in individuals with some schooling was active smoking (Table 4).

Taking into consideration the unfavorable results in the level of education and the notable differences found according to gender, the analysis of the relationship between the educational level and the presence of cardiovascular risk factors was studied in more depth. The OR of the risk factors was calculated, comparing the group with no schooling to the group with some schooling (Table 5) separately for men and women. Statistically significant differences were detected for obesity in the men and diabetes and the metabolic syndrome in the women; in all cases the risk was higher in the persons with no schooling (Table 5). In absolute terms, the risk of having any cardiovascular risk was higher in the group with no schooling, except in the case of hypercholesterolemia in the men, in whom this tended to predominate in the group with some schooling, although without reaching statistical significance.

Obesity and the Metabolic Syndrome

Obesity and the metabolic syndrome were the most prevalent variables, together with the low educational level (Table 1). An important additional characteristic was that the obesity found was predominantly abdominal. Among the individuals with a BMI ≥27, 84.5% of the men had a waist circumference >102 cm and 95.4% of the women >88 cm. Among those with a BMI <27, 21% of the men and 51.1% of the women also had a high waist circumference.

The metabolic syndrome was equally represented in men and women and increased progressively with age (Tables 1 and 3). The most prevalent diagnostic criteria for the metabolic syndrome were waist circumference and blood pressure, both predominant in the women, as opposed to triglycerides, which was the most frequent criterion in the men (Table 1).

Diabetes Mellitus

Diabetes and elevated fasting blood glucose, together with obesity, were the risk factors with the highest prevalence, as up to 56.1% of the individuals were diabetic or presented elevated blood glucose values (Table 1). Almost one quarter of the individuals in the sample were known diabetics under treatment by a primary care physician, with no differences between sex. However, the number of cases of unknown diabetes was almost double among the men (Table 1).

Hypertension

In total, 383 (44.6%) persons were known to have hypertension and were receiving therapy. Among the remaining 475, 235 (49.5%), of which 63% were men, presented a mean clinical blood pressure ≥140/90 mmHg. Only 108 (45.9%) chose to have their measurements confirmed using SMBP (37 cases) or ABPM (71 cases). In 37 of the 71 cases using ABPM, the 24 h mean blood pressure was ≥135/85 mm Hg (22 men and 15 women), and in 26 of the 37 cases using SMBP, the mean blood pressure was also ≥135/85 mm Hg (15 men and 11 women). Thus, the final percentage of hypertensive individuals in the study sample was 49%, with a significantly higher predominance among the women (Table 1).

Hypercholesterolemia

No differences were found between sexes in the prevalence of diagnosed or undiagnosed hypercholesterolemia. An increase in the prevalence related to age was only observed among the women.

DISCUSSION

The prevalence of cardiovascular risk factors found in adults from Sanlucar de Barrameda aged between 50 and 75 years was extremely high. Obesity, diabetes and, consequently, the metabolic syndrome all stand out. Of note, too, was the low educational level, with more than 50% illiteracy, predominantly in women. These prevalences are among the highest in Spain, and to date we have been unable to find a higher prevalence of obesity and the metabolic syndrome in Spain.12-28 The data on the prevalence of diabetes, together with those of the GUIA Study in the Canary Isles, are also the highest so far reported in Spain.26

The extremely high prevalence of overweight and obesity deserves special mention, and it could increase even more in the future due to the progressive increase detected among young persons and adolescents.29

Furthermore, considering that overweight and obesity are closely linked to the development of the remaining cardiovascular risk factors and that they are independently associated with mortality,30 the results found in this study are a cause for concern.

Educational Level and Prevalence of Risk Factors

Although the Sanlucar Study was not designed to investigate the causes of the prevalence of cardiovascular risk factors, we believe that the detection of such adverse findings justifies carrying out an additional analysis in order to propose a possible explanation. Since socioeconomic factors, mainly the educational level, are closely linked to the development of cardiovascular risk factors,31-34 it is plausible that the socioeconomic determinants are significantly affecting the development of risk factors in Sanlucar de Barrameda. In the age segment studied, up to 93.5% of the individuals had no schooling or only primary education (though not specifying whether these studies were in fact completed). By logistic regression analysis, the risk for obesity was 1.5 times higher among men with no schooling, after adjusting for confounding variables. Likewise, the risk for diabetes or the metabolic syndrome was more than 1.6 times higher among women with no schooling. The poor employment situation in Cadiz province is well known, with the highest unemployment rate registered in Spain35; Sanlucar de Barrameda ranks fifth in the rate of unemployment among Spanish towns with more than 50000 inhabitants, registered in 2006 (after Ceuta, Melilla, La Linea de la Concepcion, and Cadiz), and was in first position a few years ago.35

Relevance and Practical Applicability of the Results

The Sanlucar Study provides up to date data on the prevalence of the leading cardiovascular risk factors in an area with one of the highest cardiovascular morbidity and mortality rates in Spain. The results of the present study show the need for improvements in health care concerning the detection and prevention of risk factors. The efficiency of these measures would likely be limited if parallel political and social action is not taken to improve school failure, the economy, and unemployment.

Limitations of the Study

As a prevalence analysis, the limitations of the present study include the fact that it focused on one age group and did not cover the entire population, due to the design of the Sanlucar Study. Also, the prevalences of diabetes and hypertension are underestimated. Although no confirmatory readings of fasting blood glucose levels were made in the cases with values ≥126 mg/dL, we consider the real prevalence of diabetes to be underestimated since no oral glucose tolerance testing was performed on the high number of individuals with elevated fasting glucose readings. Hypertension, too, was probably underestimated, as only half of the nonhypertensive individuals with elevated blood pressure carried out SMBP and ABPM. This low percentage of acceptance of SMBP or ABPM was surprising, even though this group of individuals received information regarding the diagnostic and prognostic importance and the potential therapeutic repercussions. Finally, a characteristic that makes a rigorous comparison of results of national epidemiological studies with those of the Sanlucar Study difficult derives from the heterogeneity of the diagnostic criteria, the age groups and the methodology used. This does not significantly affect comparison of the prevalence of obesity or the metabolic syndrome. Regarding diabetes, however, and with the exception of the Canary Islands' GUIA Study, the differences in prevalence found between the Sanlucar Study and the rest of the studies are so marked that they could not be explained by methodological differences alone.

CONCLUSIONS

The prevalence of cardiovascular risk factors in adults aged 50 to 75 years from Sanlucar de Barrameda is extremely high. In particular, the prevalences of obesity, diabetes, and the metabolic syndrome were found to be among the highest so far reported in Spain. A very deficient educational level may be related with these adverse results, thus posing a health care problem of great magnitude that requires considerably increasing corrective and preventive measures.

ACKNOWLEDGEMENTS

We wish to express out gratitude to all the nurses, physicians, and participants of the Sanlucar Study.

SANLUCAR STUDY PARTICIPANTS

Miguel Ángel Barón Ramos, Antonio Bascuñana Quirell, Manuel Beltrán Robles, Javier Elvira González, Alejandro López Suárez, Joan Rosal Obrador (members of the Asociación Investigación Clínica Sanlúcar), Hugo Badani, Encarnación Benítez Rodríguez, Francisco Cañas Hormigo, Esmeralda Contreras Fernández, Ana Isabel Diosdado, Raquel Macías Bernal, Juan Ruiz de Castroviejo, Miguel Oliver Pece, Amparo Pons Raga, Miguel Rabello Formanti, Jaime Ruiz Muriel, Juan Manuel Saucedo, Manuel Sepúlveda, Isabel Solino.

ABBREVIATIONS
ABPM: ambulatory blood pressure monitoring
BMI: body mass index
DBP: diastolic blood pressure
SBP: systolic blood pressure
SMBP: self-monitored blood pressure

The researchers involved in the Sanlucar Study are given at the end.

The Fundación Doctor Pascual financed the study with a collaborative grant.


Correspondence: Dr. A. López Suárez.
Servicio de Medicina Interna. Hospital Virgen del Camino.
Ctra. de Chipiona, km 0.6. 11540 Sanlúcar de Barrameda. Cádiz. España.
E-mail: a.lopez.ssl@gmail.com

Received January 10, 2008.
Accepted for publication June 16, 2008.

Bibliography
[1]
Medrano MJ, Boix R, Cerrato E, Ramírez M..
Incidencia y prevalencia de cardiopatía isquémica y enfermedad cardiovascular en España: revisión sistemática de la literatura..
Rev Esp Salud Pub, (2006), 80 pp. 5-15
[2]
Benach J, Yasui Y, Martínez JM, Borrell C, Pasarín MI, Daponte A..
The geography of the highest mortality areas in Spain: a striking cluster in the southwestern region on the country..
Occup Environ Med, (2004), 61 pp. 280-1
[3]
Boix R, Aragonés N, Medrano MJ..
Tendencias en la mortalidad por cardiopatía isquémica en 50 provincias españolas..
Rev Esp Cardiol, (2003), 56 pp. 850-6
[4]
Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M..
Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales..
Med Clin (Barc), (2005), 124 pp. 606-12
[5]
Isomaa Bo, Almgren P, Tuomi T, Forsen B, Lahti K, Nissén M, et al..
Cardiovascular morbidity and mortality associated with the metabolic syndrome..
Diabetes Care, (2001), 24 pp. 683-9
[6]
DECODE Study Group..
Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study..
Eur J Cardiovasc Prev Rehabil, (2007), 14 pp. 192-9
[7]
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D..
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group..
Ann Intern Med, (1999), 130 pp. 461-70
[8]
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus..
Diabetes Care, (1997), 20 pp. 1183-97
[9]
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al..
The seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC-7 report..
JAMA, (2003), 289 pp. 2560-72
[10]
Friedewald WT, Levy RI, Fredrickson DS..
Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge..
Clin Chem, (1972), 18 pp. 499-502
[11]
Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants..
Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition..
[12]
Basterra-Gortari FJ, Bes-Rastroll.o, Seguí-Gómez M, Forga L, Alfredo J, Martínez-González MA..
Tendencias de la obesidad, diabetes mellitus, hipertensión e hipercolesterolemia en España (1997-2003)..
Med Clin (Barc), (2007), 129 pp. 405-8
[13]
Sánchez-Chaparro MA, Román-García J, Calvo-Bonach.o, Gómez-Larios T, Fernández-Meseguer A, Sáinz-Gutiérrez JC, et al..
Prevalencia de factores de riesgo vascular en la población laboral española..
Rev Esp Cardiol, (2006), 59 pp. 421-30
[14]
Pallarés-Carratalá V, Piñón-Sellés F, Diago-Torrent JL..
Diabetes mellitus y otros factores de riesgo cardiovascular mayores en una población del Mediterráneo español. Estudio Burriana..
Endocrinol Nutr, (2006), 53 pp. 158-67
[15]
Aranceta J, Pérez C, Serra L, Ribas L, Quiles J, Vioque J, et al..
Prevalencia de la obesidad en España: resultados del estudio SEEDO 2000..
Med Clin (Barc), (2003), 120 pp. 608-12
[16]
Estudio DORICA: dislipidemia, obesidad y riesgo cardiovascular. In: Aranceta J, Foz M, Gil B, Jover E, Mantilla T, Millán J, et al, editors. Obesidad y riesgo cardiovascular. Estudio DORICA. Madrid: Panamericana; 2004. p. 125-56.
[17]
Rigo F, Frontera G, Lobera J, Rodríguez T, Borrás I, Fuentespina E..
Prevalencia de factores de riesgo cardiovascular en las Islas Baleares (estudio CORSAIB)..
Rev Esp Cardiol, (2005), 58 pp. 1411-9
[18]
Gutiérrez-Fisac JL, López E, Benegas JR, Graciani A, Rodríguez-Artalejo F..
Prevalence of overweight and obesity in elderly people in Spain..
Obes Res, (2004), 12 pp. 710-5
[19]
Álvarez E, Ribas L, Serra L..
Prevalencia del síndrome metabólico en la población de la Comunidad Canaria..
Med Clin (Barc), (2003), 120 pp. 172-4
[20]
Alegría E, Cordero A, Laclaustra M, Grima A, León M, Casanovas JA, et al..
Prevalencia del síndrome metabólico en la población laboral española..
Rev Esp Cardiol, (2005), 58 pp. 797-806
[21]
Martínez-Larrand MT, Fernández-Pérez C, González-Sánchez JL, López A, Fernández-Álvarez J, Riviriego J, et al..
Prevalencia del síndrome metabólico (criterios del ATP-III). Estudio de base poblacional en áreas rural y urbana de la provincia de Segovia..
Med Clin (Barc), (2005), 125 pp. 481-6
[22]
Calbo JM, Terrancle I, Fernández P, Rodríguez MJ, Martínez V, Santisteban Y, et al..
Prevalencia del síndrome metabólico en la provincia de Albacete..
Rev Clin Esp, (2007), 207 pp. 64-8
[23]
Baena JM, del Val JL, Tomás J, Martínez JL, Martín R, González I, et al..
Epidemiología de las enfermedades cardiovasculares y factores de riesgo en atención primaria..
Rev Esp Cardiol, (2005), 58 pp. 367-73
[24]
Masiá R, Sala J, Rohifs I, Piulats R, Manresa J, Marrugat J..
Prevalencia de diabetes mellitus en la provincia de Girona, España: el estudio REGICOR..
Rev Esp Cardiol, (2004), 57 pp. 261-4
[25]
Muñiz J, Cordido F, López I, Castro A..
Effect of the application of the new diagnostic criteria of diabetes mellitus in the prevalence estimates and diagnostic level in the general population..
Eur J Pub Health, (1999), 9 pp. 149-51
[26]
de Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F, Anía BJ, Losada A, Betancor P..
Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population —comparison of the 1997 ADA and the 1985 WHO criteria. The Guía Study..
Diabet Med, (2001), 18 pp. 235-41
[27]
Vara-González L, Muñoz P, Sanz S..
Prevalencia, detección, tratamiento y control de la hipertensión arterial en Cantabria en 2002..
Rev Esp Salud Pub, (2007), 81 pp. 211-9
[28]
Banegas JR, Villar F, Pérez C, Jiménez R, Gil E, Muñiz J, et al..
Estudio epidemiológico de los factores de riesgo cardiovascular en la población española de 35 a 64 años..
Rev San Hig Pub, (1993), 67 pp. 419-45
[29]
Serra-Majem L, Aranceta J, Pérez-Rodrigo C, Ribas-Barba L, Delgado-Rubio A..
Prevalence and determinants of obesity in Spanish children and young people..
Br J Nutr, (2006), 96 pp. S67-72
[30]
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al..
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old..
N Engl J Med, (2006), 355 pp. 763-78
[31]
Winkleby MA, Jatulis DE, Frank E, Fortmann SP..
Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease..
Am J Public Health, (1992), 82 pp. 816-20
[32]
Iribarren C, Luepker RV, McGovern PG, Arnett DK, Blackburn H..
Twelve-year trends in cardiovascular disease risk factors in the Minnesota Heart Survey..
Are socioeconomic differences widening? Arch Intern Med, (1997), 157 pp. 873-81
[33]
Cirera L, Tormo MJ, Chirlaque MD, Navarro C..
Cardiovascular risk factors and educational attainment in Southern Spain: a study of a random sample of 3091 adults..
Eur J Epidemiol, (1998), 14 pp. 755-63
[34]
Robbins JM, Vaccarino V, Zhang H, Kasl SV..
Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the third national health and nutrition examination survey..
Am J Public Health, (2001), 91 pp. 76-83
[35]
Anuario económico de España 2007. Available from: www.estudios.laCaixa.es/anuarioeconomico
Are you a healthcare professional authorized to prescribe or dispense medications?